British Columbia Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-35,955
Closed -$6.37M 851
2020
Q1
$6.37M Sell
35,955
-1,262,476
-97% -$238M 0.11% 165
2019
Q4
$248M Buy
1,298,431
+1,231,812
+1,849% +$222M 1.85% 8
2019
Q3
$11.2M Buy
66,619
+1,587
+2% +$259K 0.11% 183
2019
Q2
$10.9M Buy
65,032
+1,858
+3% +$257K 0.1% 211
2019
Q1
$9.25M Sell
63,174
-32,467
-34% -$4.71M 0.08% 248
2018
Q4
$12.8M Buy
95,641
+8,780
+10% +$1.44M 0.11% 191
2018
Q3
$16.5M Sell
86,861
-22,818
-21% -$4.19M 0.18% 126
2018
Q2
$18.3M Sell
109,679
-15,505
-12% -$2.49M 0.16% 144
2018
Q1
$21.1M Sell
125,184
-24,861
-17% -$4.17M 0.16% 151
2017
Q4
$24.5M Sell
150,045
-33,079
-18% -$5.94M 0.17% 141
2017
Q3
$37.5M Buy
183,124
+3,480
+2% +$809K 0.29% 74
2017
Q2
$43.7M Buy
179,644
+14,082
+9% +$3.31M 0.35% 60
2017
Q1
$39.6M Sell
165,562
-25,524
-13% -$5.94M 0.31% 64
2016
Q4
$40.1M Buy
191,086
+26,071
+16% +$5.4M 0.35% 62
2016
Q3
$38M Sell
165,015
-29,527
-15% -$7.22M 0.38% 56
2016
Q2
$45M Sell
194,542
-30,358
-13% -$7M 0.39% 55
2016
Q1
$60.3M Buy
224,900
+5,351
+2% +$1.53M 0.57% 42
2015
Q4
$68.6M Sell
219,549
-73,641
-25% -$21.9M 0.66% 35
2015
Q3
$79.7M Buy
293,190
+140
+0% +$43K 0.81% 22
2015
Q2
$88.9M Buy
293,050
+5,465
+2% +$1.63M 0.85% 17
2015
Q1
$85.6M Buy
287,585
+164,683
+134% +$47M 0.77% 22
2014
Q4
$31.6M Sell
122,902
-19,612
-14% -$4.9M 0.26% 100
2014
Q3
$34.4M Buy
142,514
+28,457
+25% +$6.37M 0.29% 88
2014
Q2
$25.4M Buy
114,057
+11,275
+11% +$2.33M 0.21% 127
2014
Q1
$21.2M Sell
102,782
-18,758
-15% -$3.72M 0.18% 147
2013
Q4
$20.4M Buy
121,540
+34,226
+39% +$5.35M 0.16% 162
2013
Q3
$12.6M Sell
87,314
-11,895
-12% -$1.58M 0.11% 229
2013
Q2
$12.5M Buy
+99,209
New +$11.2M 0.1% 227

Other funds holding AGN

British Columbia Investment Management's AGN Position: Q2 2020 in Review

British Columbia Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 35,955 shares — an estimated $6.37M sold.

British Columbia Investment Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $248M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • British Columbia Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • British Columbia Investment Management sold 35,955 Allergan plc shares in Q2 2020, an estimated $6.37M.
  • British Columbia Investment Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • British Columbia Investment Management's Allergan plc position peaked at $248M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on British Columbia Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.